Thanks again to all the visitors who were attending the RoB workshop. We’re grateful for your support in our workshop. See you next time!!

Key messages • Overall, we did not find sufficient evidence to show that medicines that block interleukin-1 (a protein involved in immune responses) are effective treatments for people with COVID-19, or whether they cause unwanted effects. • We found 16 studies with unpublished results. We will update this review when new data are available. • In future, we need high-quality studies to evaluate medicines that block interleukin-1 to treat COVID-19. 

【Event】Systematic review and meta-analysis workshop

What was studied in the review?In order to reduce the spread of the virus that causes COVID-19, many governments and societies put mitigation measures in place in schools. However, we do not know whether these measures work with regards to reducing the spread of the virus, or how these measures affect other aspects of life, such as education, the economy or society as a whole. 

If you want more information, please follow Cochrane Taiwan Facebook, IG, Line! It's FREE!DATE：14, February, 2022 , pm12:00~13:00

Welcome to Join Cochrane FamilyBecome a translator：https://reurl.cc/V5oN5Y

【2022 RoB 2.0, Newcastle-Ottawa Scale, ROBINS-I Workshop】

The COVID-19 pandemic and its associated measures have brought added urgency to the need for sustainable health care.[1,2] The rapid reorganization of health care and the drive to initiate new research has contributed to a substantial burden on financial and human resources.

Celebrate Thanksgiving, and book discounts are coming!一年一度的感恩節即將到來，準備要去吃大餐了嗎？感恩節當天購買GRADE書籍輸入折扣碼享有88折優惠喔!!折扣碼：ASIA2021折扣碼使用期限：11/25 00:00~23:59

For the month of October, Cochrane is co-hosting a